Invention Grant
- Patent Title: Immunogenic RSV polypeptides
-
Application No.: US15562862Application Date: 2016-02-18
-
Publication No.: US10744193B2Publication Date: 2020-08-18
- Inventor: Surender Khurana , Hana Golding
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: US MD Silver Spring
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US MD Silver Spring
- Agency: Klarquist Sparkman, LLP
- International Application: PCT/US2016/018530 WO 20160218
- International Announcement: WO2016/160166 WO 20161006
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K14/135 ; A61P31/14 ; C12N7/00 ; G01N33/569 ; A61K39/00
Abstract:
This invention provides immunogenic compositions comprising an immune stimulant and an respiratory syncytial virus (RSV) oligopeptide or an unglycosylated RSV polypeptide. The RSV oligopeptides are shown in SEQ ID NO: 3-33. The unglycosylated RSV polypeptide may consist essentially of the ectodomain of an RSV G protein, such as that shown in SEQ ID NO: 2 or the ectodomain of an RSV F protein such as the ectodomain of the F protein shown in SEQ ID NO: 39.
Public/Granted literature
- US20180110850A1 IMMUNOGENIC RSV POLYPEPTIDES Public/Granted day:2018-04-26
Information query
